Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Consumer DNA testing has transformed how millions of people explore their heritage and health. Since the first direct-to-consumer kits hit the market over a decade ago, more than 30 million people have submitted their saliva samples hoping to uncover ancestral origins, find biological relatives, or gain health insights. Yet an interesting question lingers for early adopters: is retaking DNA test worth it in 2026? Your genetic code remains unchanged, but the technology used to read it has evolved dramatically.
The answer depends on several factors that have shifted significantly in recent years. Testing companies continuously refine their reference populations, upgrade their DNA chips, and improve imputation algorithms. Meanwhile, the 2026 landscape includes major industry disruptions like the 23andMe bankruptcy that raise new questions about data stability and privacy. Whether you tested five years ago or just last month, understanding these technological and market changes will help you make an informed decision about investing in a second test.
This guide examines when retaking a DNA test genuinely adds value, when it merely duplicates existing information, and how recent developments in genetic genealogy might affect your choice. We will explore the science behind autosomal DNA testing, compare major testing providers, and address the practical considerations every consumer should weigh before purchasing another kit.
DNA testing has become an instrumental tool in genealogy, health screening, and determining genetic links.

However, there are instances when the results might not be as clear-cut or comprehensive as one would hope. Here is when you might consider retaking a DNA test to get clearer insights.
By considering these factors and possibly retaking a DNA test under the right circumstances, individuals can gain further clarity and understanding of their genetics that was previously not possible due to various limitations of earlier tests.
Also Read: Best DNA Health Test: Find Your Genetic Wellness Solution!
Understanding what changes between your first and second DNA test requires grasping how testing companies analyze your genetic material. When you submit a saliva sample, the laboratory extracts your autosomal DNA and processes it through a genotyping array that examines hundreds of thousands of single nucleotide polymorphisms (SNPs) across your genome. These SNPs serve as markers that help estimate your ancestry composition and identify genetic relatives.

Your initial DNA test results provide a baseline of genetic information that can be incredibly eye-opening. These results typically include your ethnicity estimate, showing percentages tied to different geographic regions, along with potential health risks linked to specific genes and traits inherited from ancestors. The first test also establishes your profile in the company’s database for relative matching.
When undertaking a second DNA test with a different company or after several years have passed, you may notice variations in your results. These differences stem from several factors: diverse reference populations used by each testing company, improvements in imputation technology that fills in genetic gaps algorithmically, and updated DNA chip versions that examine different SNP sets. Companies periodically revise their ethnicity estimate algorithms as they gather more samples from underrepresented regions.
Comparing outcomes side-by-side offers a broader view of your ancestral origins by possibly uncovering more detailed regional ancestry or refining percentages associated with particular ethnicities. However, core findings like close family connections and your fundamental genetic makeup remain stable. The evolution in health-related genetic markers can also provide more nuanced insights into hereditary conditions or carrier statuses for certain diseases, particularly if you choose one of the best DNA health test options available today.
Delving into the specifics of each test allows you to construct a richer narrative of your lineage and health profile. It underscores the dynamic nature of genetic genealogy where ongoing developments continually enhance our understanding. This comparative analysis not only enriches personal genealogical exploration but also highlights how reference populations and imputation methods affect your reported results.
Also Read: Unveiling MacConkey Agar: Composition, Principles, and Uses
While a single test provides a wealth of information about ancestry, health predispositions, and traits, subsequent tests might uncover more nuanced details due to advancements in genetic research, differences in data interpretation, and unique databases across testing services.

Here are some key benefits you might experience:
Taking advantage of multiple DNA tests can deepen your understanding of your heritage, and genetics-related health conditions, and bring you into contact with a broader community of people who share parts of your genetic makeup all while leveraging the latest in genomic science for personal discovery.
Understanding whether retaking a DNA test adds value requires familiarity with how these tests actually work. All major consumer testing companies use autosomal DNA analysis, which examines chromosomes inherited from both parents. Unlike Y-DNA or mitochondrial DNA tests that trace specific paternal or maternal lines, autosomal testing provides a comprehensive view across your entire genome but becomes less reliable for ancestry beyond five to seven generations.
The core technology behind these tests involves SNP arrays, commonly called DNA chips. These chips contain microscopic probes that detect specific genetic variations at predetermined positions in your genome. When 23andMe, AncestryDNA, or MyHeritage process your sample, they are essentially checking which versions of these SNPs you carry. Each company uses slightly different chip versions, with newer iterations examining more SNP positions and including markers relevant to recent health discoveries.
A crucial concept in modern genetic genealogy is imputation, a computational technique that fills in genetic data between tested SNPs. Rather than sequencing your entire genome, which remains prohibitively expensive, companies use statistical models to predict untested genetic variants based on patterns in reference populations. This process allows companies to provide ancestry and health reports without examining every base pair of your DNA. However, imputation accuracy varies depending on population coverage and the density of SNPs tested.
Backwards compatibility presents another important consideration. When companies upgrade their DNA chips to newer versions, they face a challenge: how to compare results between customers tested on different chip generations. Most major providers have developed sophisticated methods to harmonize data across chip versions, meaning your older test results remain comparable to newer ones in their relative matching databases. However, backwards compatibility has limits, and some advanced features may only work for customers tested on recent chip versions.
DNA chip upgrades happen periodically as technology improves. 23andMe, for example, has released multiple chip versions over the years, with each iteration adding SNPs relevant to newly discovered health associations. AncestryDNA and MyHeritage have followed similar upgrade paths. While these upgrades primarily benefit new customers, existing customers sometimes receive updated ancestry estimates as companies improve their reference populations and algorithms without requiring a new test.
The genetic testing landscape shifted dramatically in March 2025 when 23andMe filed for Chapter 11 bankruptcy protection, sending shockwaves through the consumer genomics industry. Once valued at nearly $6 billion after its public listing, the company struggled with declining sales and failed attempts to pivot toward drug development using its massive genetic database. This bankruptcy raises critical questions for anyone considering whether retaking DNA test worth it, particularly regarding data privacy and long-term service stability.
The immediate concern centers on what happens to the genetic data of 15 million customers. During bankruptcy proceedings, 23andMe’s assets including its valuable genetic database may be sold to cover debts. While the company has stated that its privacy policies remain in effect, legal experts note that bankruptcy courts can alter contractual obligations. This uncertainty makes many consumers wary of submitting new samples or even maintaining existing accounts with the service.
For those contemplating a second DNA test, the 23andMe bankruptcy serves as a reminder to carefully evaluate company stability before investing. While raw genetic data can be downloaded and transferred to third-party tools like GEDmatch or the DNA Painter tool, proprietary features like relative matching and health reports depend on the company remaining operational. If 23andMe assets are acquired by another entity, the new owner could theoretically change privacy terms or business focus.
This industry disruption also affects the competitive landscape. With 23andMe’s future uncertain, AncestryDNA and MyHeritage have captured market share from consumers seeking more stable alternatives. For those who previously tested with 23andMe, retaking with a different provider offers both fresh results and the security of working with a company not undergoing financial restructuring. The bankruptcy underscores the importance of downloading your raw DNA data promptly and considering how company longevity affects your genetic genealogy strategy.
Deciding whether to retake a DNA test often involves choosing a different provider than your original choice. Each major testing company offers distinct strengths, database characteristics, and analysis approaches that can significantly affect your results and genealogical experience.
AncestryDNA maintains the largest consumer genetic database with over 20 million testers, making it the premier choice for relative matching in genetic genealogy. Their ethnicity estimates emphasize broad geographic regions with solid coverage of European ancestry. AncestryDNA integrates seamlessly with their extensive genealogical records subscription service, allowing you to build family trees and connect DNA matches to documented lineages. However, they discontinued their health testing features, focusing purely on ancestry and traits.
23andMe pioneered direct-to-consumer health testing alongside ancestry analysis. Their health reports cover carrier status, health predispositions, and wellness traits with FDA-cleared assessments for certain conditions. Their ancestry composition provides detailed regional breakdowns and haplogroup information. As noted, their 2026 bankruptcy creates uncertainty about future services. Their database, while smaller than AncestryDNA’s, contains health-conscious participants who often provide rich family history context.
MyHeritage offers competitive ancestry testing with particular strength in European and Jewish genealogy. Their DNA matching includes innovative tools like chromosome browsers and auto-clustering of matches. The company has aggressively expanded its database through strategic testing initiatives in underserved regions. MyHeritage provides health upgrades for existing ancestry tests, allowing customers to access health insights without submitting new samples. Their family tree building tools and historical record collections complement DNA testing effectively.
FamilyTreeDNA focuses on serious genealogists with comprehensive testing options including Y-DNA and mitochondrial DNA tests that trace direct paternal and maternal lines across deep timeframes. Their autosomal test integrates with projects focused on surname studies and geographic origins. FamilyTreeDNA permits law enforcement matching, which concerns some privacy advocates but has helped solve cold cases. Their database is smaller but contains dedicated genealogists often willing to collaborate extensively.
For someone considering retaking a DNA test, switching between these providers often yields the most significant new insights. Each company maintains separate databases, meaning relatives tested with AncestryDNA will not appear in your 23andMe match list and vice versa. Testing with multiple companies maximizes your chances of finding key genetic relatives, especially for adoptees or those with brick walls in their family trees.
With the continuous advancement in genetic testing technology and the expansion of genetic databases, taking another test could potentially provide you with new insights into your ancestry, health predispositions, and even potential relatives. However, before jumping into retaking a DNA test in 2026, there are several important considerations to keep in mind:
By thoughtfully considering these points before proceeding with retesting, you can ensure that taking another DNA test is both a meaningful and informed decision. The landscape of genetic genealogy continues evolving rapidly, making it essential to approach retesting with clear goals and appropriate expectations.
Also Read: Which DNA Matches to Research First? – 3 Key Steps
Visual explanations can help clarify the complex science behind DNA testing. The following video provides an overview of how direct-to-consumer genetic testing works, what information these tests can and cannot provide, and considerations for anyone thinking about taking or retaking a DNA test.
Video content offers accessible explanations of technical concepts like SNP analysis, imputation, and reference populations that affect your ethnicity estimate. Watching expert discussions about DNA chip technology and backwards compatibility can supplement the written information in this guide and help you make a more informed decision about retesting.
It is not strictly necessary, but it can be helpful depending on your goals. Testing companies periodically update their ethnicity estimate algorithms and reference populations, meaning your existing results may automatically refresh without requiring a new test. However, if your original test used an older DNA chip with fewer SNPs, a retest with current technology could provide more detailed health insights and slightly refined ancestry breakdowns. Your core genetic relatives will not change your DNA does not mutate over time but the number of people in matching databases grows daily, so a new test with a different company might connect you with relatives who never tested with your original provider.
Yes, a second DNA test can reveal different health information, though the underlying genetic variants remain unchanged. Several factors explain these differences. First, testing companies use different DNA chips that examine varying sets of SNPs, meaning one company might test for health markers that another misses. Second, companies interpret the same genetic data differently based on their scientific literature reviews and risk models. Third, health databases evolve constantly; a test taken in 2026 includes research discoveries not available when you first tested. Finally, some companies like AncestryDNA have discontinued health testing entirely, while others like 23andMe and MyHeritage continue expanding their health reports. If health insights drive your decision to retest, compare current offerings carefully rather than assuming all companies provide equivalent information.
Your documented family tree built through traditional genealogy remains unchanged by DNA testing. However, your genetic family tree the network of biological relationships revealed through DNA matching may expand significantly when you test with additional companies. Each DNA testing service maintains separate databases, so relatives who tested with AncestryDNA will not appear in your 23andMe results and vice versa. Your close family matches with parents, siblings, and immediate cousins will remain consistent across platforms because you share substantial amounts of autosomal DNA that all companies detect reliably. More distant matches may vary between services due to different matching thresholds and imputation methods. Additionally, the 23andMe bankruptcy in 2025 raises questions about long-term database access, suggesting that diversifying your genetic genealogy presence across multiple stable companies protects your research against corporate disruption.
Making this decision requires evaluating several personal factors against the cost and potential benefits. Start by defining your primary goal: are you seeking refined ethnicity estimates, health insights, or biological relatives? If you want better relative matching and already tested with a smaller service, retaking with AncestryDNA makes sense given their 20 million person database. For health information, compare whether uploading existing data to third-party tools or purchasing health upgrades from your current provider offers better value than a new test. Consider timing: if you tested before 2018, DNA chip upgrades since then provide meaningful improvements in SNP coverage. Evaluate privacy comfort given the 23andMe bankruptcy and evolving data policies. Finally, assess whether your curiosity level justifies the $60-$200 expense when your raw genetic data could be reanalyzed through services like GEDmatch or the u003ca href=u0022https://aboutdarwin.com/which-dna-matches-to-research-first-3-key-steps/u0022u003eDNA Painter toolu003c/au003e at lower cost. The answer to u0022is retaking DNA test worth itu0022 ultimately depends on whether your specific genealogical or health questions remain unanswered by your existing results.
Also Read: Post-Earthquake Guide: Safeguard Against Infectious Diseases
Determining whether retaking DNA test worth it requires balancing technological realities against personal goals and financial considerations. Your DNA itself remains constant, but the methods used to read, interpret, and compare it continue evolving. For those who tested years ago on early chip versions, a retest offers modest improvements in SNP coverage and ancestry resolution. For individuals seeking biological relatives, testing with multiple companies maximizes database exposure and increases discovery odds. The 23andMe bankruptcy in 2025 adds an important wrinkle, reminding consumers that corporate stability affects long-term access to genetic data and relative matching services.
Before purchasing another kit, exhaust the value of your existing results through third-party tools like GEDmatch, the DNA Painter tool, and various chromosome browsers. These resources often extract insights from raw data without requiring new testing. If you proceed with retesting, choose your provider strategically based on whether ancestry depth, health reports, or relative matching matters most for your research.
The genetic genealogy landscape in 2026 offers more options than ever, but also demands greater awareness of privacy implications and company stability. By understanding imputation technology, reference population limitations, and the differences between AncestryDNA, 23andMe, MyHeritage, and FamilyTreeDNA, you position yourself to make informed decisions about your genetic journey. Whether you choose to retest or work with existing data, the field of genetic genealogy continues offering unprecedented opportunities to connect with your heritage and biological family.